- Home
- VCYT vs TENB Comparison
VCYT vs TENB Comparison
Compare VCYT & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCYT | TENB |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VCYT | TENB |
|---|---|---|
| Price | $56.85 | $39.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $44.00 | $31.69 |
| AVG Volume (30 Days) | 1.4M | ★ 3.5M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | 3.23 |
| EPS | ★ 0.35 | 0.01 |
| Revenue | N/A | ★ $999,405,000.00 |
| Revenue This Year | $13.76 | $9.37 |
| Revenue Next Year | $12.35 | $7.04 |
| P/E Ratio | ★ $162.77 | $3,978.00 |
| Revenue Growth | N/A | ★ 11.04 |
| 52 Week Low | $22.61 | $15.73 |
| 52 Week High | $60.91 | $42.94 |
Technical Indicators
Market Signals| Indicator | VCYT | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 71.52 |
| Support Level | $40.27 | $25.61 |
| Resistance Level | $60.91 | N/A |
| Average True Range (ATR) | 2.83 | 2.45 |
| MACD | -0.51 | 0.60 |
| Stochastic Oscillator | 56.84 | 80.39 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.